Inhibrx Biosciences Inc. (INBX)

INBX trades at $35.65, 42.6% above the near-term max pain of $25 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($10-$25), reflecting growing call interest at higher strikes. Key magnetic zone at 20 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for INBX shows an upward trend from 10 to 25, suggesting bullish positioning in longer-dated options. The 75% spread signals divergent expectations across timeframes. Most levels below 35.65 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.